Table 2.
Variable | Category | Hazard ratio | 95% CI | P‐value |
---|---|---|---|---|
Age (year) | <57 | 1 | 1.08–7.24 | 0.03 |
≥57 | 2.80 | |||
Gender | Female | 1 | 0.49–2.06 | 0.99 |
Male | 1.00 | |||
Histological types | Papillary | 1 | 1.52–6.44 | 0.002 |
Non‐papillary | 3.13 | |||
Metastasis | No | 1 | 1.23–6.29 | 0.014 |
Presence | 2.78 | |||
HO‐1 staining | Low | 1 | 1.16–5.08 | 0.019 |
High | 2.42 | |||
Adjuvant chemotherapy | No | 1 | ||
5‐FU‐based | 0.49 | 0.17–1.38 | 0.176 | |
Oral fluoropyrimidine | 1.73 | 0.82–3.65 | 0.149 |